Jon P. Stonehouse, CEO at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 2,463 shares at $7.06 ($17K) on 2007-07-31, disclosed to the SEC on 2007-08-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| BCRX | SELL | 2022-12-19 | $154K | — | Filing → |
| BCRX | SELL | 2022-12-02 | $4.9M | — | Filing → |
| BCRX | SELL | 2022-01-13 | $2.8M | — | Filing → |